Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors[1], studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes[2][3]. With an extended half-life of approximately 6 days, this peptide enables convenient once-weekly subcutaneous dosing with a gradual titration protocol to optimize tolerability[1][4].
- Reconstitute: Add 2.0 mL bacteriostatic water → 10.0 mg/mL concentration for optimal weekly doses.
- Typical weekly range: 2–12 mg once weekly (gradual escalation over 12+ weeks).
- Easy measuring: With the Epipen turn the dial to 30 clicks. This is the starting dose equals to 20 Units on a insulin 1 ml needle.
- Storage: Reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F).
Technical Specifications:
Synonyms: LY3437943
Chemical Formula: C₂₄H₃₄Cl₂N₆O₄
CAS Number: 2381089-83-2
Molecular Weight: Approx. 5,534 g/mol
Purity: ≥99.0% (validated by Certificate of Analysis)
Appearance: White to off-white lyophilized powder
Peptide Length: 39 amino acids
Solubility: Fully soluble in water (H₂O)
Quality Verification: Confirmed by RP-HPLC analysis
Storage Conditions: Store dry at 2–8 °C; reconstituted material refrigerated and used within 6 weeks
Source: https://peptidedosages.com/single-peptide-dosages/retatrutide-20-mg-vial-dosage-protocol/
Research Use Only: Not for human or veterinary use.
The starter kits contain:
1 x Retatrutide Vial 20mg vial
1 x Epipen
10 x Epipen Needles
10 x Alcohol Wipes









